KristinaApr 250 min readManufacturer Restrictions - Latest Letters 4/25/2024Choose a ManufactureGilead 1.1.24.pdfDownload PDF • 130KBAbbVie. Download • 298KBAmgen. Download • 204KBAstellas. Download • 326KBAstraZeneca. Download • 202KBBausch. Download • 144KBBayer. Download • 198KBBiogin 12.1.23Download 23 • 825KBBoehringer Ingelheim. Download • 476KBBristol-Myers Squibb. Download • 165KBEisai. Download • 292KBEli Lilly. Download • 188KBEMD Serono. Download • 170KBExelixis. Download • 600KBGilead. Download • 228KBGlaxoSmithKline. Download • 133KBIncyte. Download • 1.02MBJazz. Download • 255KBJohnson & Johnson. Download • 142KBMerck. Download • 270KBNovartis. Download • 438KBNovo Nordisk. Download • 163KBOrganon. Download • 234KBPfizer. Download • 365KBSandoz. Download • 532KBSanofi. Download • 102KBTakeda 12.12.23Download 23 • 171KBTeva. Download • 110KBUCB. Download • 1.38MBUnited Therapeutics. Download • 105KB2024 EMDS AR Covered Entity Communication.pdfDownload PDF • 211KBAR Novartis CE Letter March 18 2024.pdfDownload PDF • 156KB340b-sanofi-covered-entity-letter.pdfDownload PDF • 102KB
Choose a ManufactureGilead 1.1.24.pdfDownload PDF • 130KBAbbVie. Download • 298KBAmgen. Download • 204KBAstellas. Download • 326KBAstraZeneca. Download • 202KBBausch. Download • 144KBBayer. Download • 198KBBiogin 12.1.23Download 23 • 825KBBoehringer Ingelheim. Download • 476KBBristol-Myers Squibb. Download • 165KBEisai. Download • 292KBEli Lilly. Download • 188KBEMD Serono. Download • 170KBExelixis. Download • 600KBGilead. Download • 228KBGlaxoSmithKline. Download • 133KBIncyte. Download • 1.02MBJazz. Download • 255KBJohnson & Johnson. Download • 142KBMerck. Download • 270KBNovartis. Download • 438KBNovo Nordisk. Download • 163KBOrganon. Download • 234KBPfizer. Download • 365KBSandoz. Download • 532KBSanofi. Download • 102KBTakeda 12.12.23Download 23 • 171KBTeva. Download • 110KBUCB. Download • 1.38MBUnited Therapeutics. Download • 105KB2024 EMDS AR Covered Entity Communication.pdfDownload PDF • 211KBAR Novartis CE Letter March 18 2024.pdfDownload PDF • 156KB340b-sanofi-covered-entity-letter.pdfDownload PDF • 102KB